Cite
HARVARD Citation
Swords, R. et al. (n.d.). Pevonedistat (MLN4924), a First‐in‐Class NEDD8‐activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study. British journal of haematology. pp. 534-543. [Online].